AGNCP - AGNC Investment Corp. Stock Analysis | Stock Taper
Logo
AGNC Investment Corp.

AGNCP

AGNC Investment Corp. NASDAQ
$24.95 -0.39% (-0.10)

Market Cap $9.76 B
52w High $25.57
52w Low $23.37
Dividend Yield 8.46%
Frequency Quarterly
P/E -13.41
Volume 271.98K
Outstanding Shares 391.22M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $1.26B $-434M $954M 75.83% $0.89 $1.69B
Q3-2025 $779M $-775M $806M 103.47% $0.73 $1.56B
Q2-2025 $289M $-242M $-140M -48.44% $-0.17 $528M
Q1-2025 $-407M $-1.16B $50M -12.29% $0.02 $737M
Q4-2024 $2.8B $1.93B $122M 4.36% $0.1 $863M

What's going well?

Revenue jumped 61% and net income rose 18%, showing strong business momentum. Expenses dropped sharply, making the company much more efficient. Margins are extremely high, and earnings per share are up.

What's concerning?

Heavy reliance on interest income and high interest expenses could be risky if rates change. Revenue is volatile, not steady, and there is little detail on what drives the business or future sustainability.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $602M $115.08B $102.68B $12.39B
Q3-2025 $450M $108.97B $97.53B $11.44B
Q2-2025 $656M $102.02B $91.67B $10.35B
Q1-2025 $455M $95.89B $85.85B $10.04B
Q4-2024 $505M $88.02B $78.25B $9.76B

What's financially strong about this company?

Shareholder equity is still positive and grew $1 billion this quarter. Most assets are tangible or financial, with little goodwill risk.

What are the financial risks or weaknesses?

Short-term debt ballooned to $101.7 billion, far outstripping cash and current assets. Liquidity is at crisis levels, and negative retained earnings show a history of losses.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $954M $128M $-11.36B $11.06B $-169M $128M
Q3-2025 $806M $153M $-5.34B $5.22B $39M $153M
Q2-2025 $-140M $180M $-3.44B $3.42B $154M $180M
Q1-2025 $50M $192M $-5.73B $5.48B $-53M $192M
Q4-2024 $122M $79M $4.93B $-5.02B $-15M $79M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at AGNC Investment Corp.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key positives include a strong recent rebound in reported earnings, a balance sheet that appears far less levered than in the past, and a focused franchise in high‑quality, liquid agency mortgage‑backed securities. The company benefits from scale, internal management, sophisticated risk tools, and good funding relationships, all of which can support spread income and help protect book value across cycles. Its specialist focus and experienced team are important intangible assets.

! Risks

Major risks center on volatility and data quality. Earnings and revenue have been highly erratic, with some of the recent strength driven by fair‑value movements and unusual expense patterns that may not recur. Operating and free cash flow have weakened even as dividends have grown, raising questions about the depth of the underlying cash engine. The business remains inherently exposed to interest‑rate shocks, funding market strain, and policy changes, and reported balance‑sheet anomalies make it harder to precisely gauge short‑term liquidity and leverage from this dataset alone.

Outlook

The forward picture is balanced. If interest rates stabilize or decline in an orderly way and funding remains accessible, AGNC’s scale, expertise, and hedging capabilities position it to continue generating meaningful income from its agency MBS portfolio. However, the combination of thin cash flow coverage, reliance on capital markets, and structurally high sensitivity to macro conditions means future results could still swing sharply. The sustainability of the current strong profit levels will depend on how well management navigates the next phase of the rate and credit cycle and whether they can translate accounting gains into durable, cash‑backed returns.